| Class 536 | ORGANIC COMPOUNDS -- PART OF THE CLASS 532-570 SERIES |
| Click here for a printable version of this file | |
Expand/Contract Processing Please Wait
| This Class 536 is considered to be an integral part of Class 260 (see the Class 260 schedule for the position of this Class in schedule hierarchy). This Class retains all pertinent definitions and class lines of Class 260. | ||
| ORGANIC COMPOUNDS (CLASS 532, SUBCLASS 1) |
![[List of Pre Grant Publications for class 536 subclass 1.11]](../as.gif) | ![[List of Patents for class 536 subclass 1.11]](../ps.gif) | 1.11 |  Carbohydrates or derivatives |
| | 2 |  Pectin or derivative |
| | 3 | Algin or derivative |
| | 4.1 | O- or S- Glycosides |
| | 4.4 |  Aescin or derivative |
| | 5 | Cyclopentanohydrophenanthrene ring system |
| | 6 |  Oxygen containing six-membered hetero ring (e.g., oxathiane, etc.) |
| | 6.1 | Oxygen containing five-membered hetero ring |
| | 6.4 | Daunomycin or derivative |
| | 6.5 | Oxygen containing hetero ring having at least twenty members (e.g., amphotericin, nystatin, pimaricin, etc.) |
| | 7.1 | Oxygen containing hetero ring having 12-19 members (e.g., methymycin, carbomycin, spiramycin, etc.) |
| | 8 | Flavon sugar compounds |
| | 8.8 | Coumermycin or derivative |
| | 13 | Novobiocin or derivative |
| | 13.1 | Antibiotic BM 123 or derivative |
| | 13.2 | Neomycin B or neomycin C or derivative |
| | 13.3 | Paromomycin or derivative (e.g., neomycin E, etc.) |
| | 13.4 | Antibiotic XK or derivative |
| | 13.5 | Butirosin or derivative (e.g., ambutyrosin, etc.) |
| | 13.6 | Gentamicin or derivative |
| | 13.7 | Kanamycin or derivative |
| | 13.9 | Sisomicin or derivative |
| | 14 | Streptomycin or derivative |
| | 16.1 | Fortimicin or derivative |
| | 16.2 | Lincomycin or derivative |
| | 16.3 | Cyano or -COO- containing |
| | 16.4 | Additional sulfur containing |
| | 16.5 | Phosphorus or halogen containing |
| | 16.6 | Neamine or derivative (e.g., neomycin A, etc.) |
| | 16.7 | Kasugamycin or derivative |
| | 16.8 | Antibiotics |
| | 17.1 | Boron, phosphorus, heavy metal or aluminum containing |
| | 17.2 | Nitrogen containing |
| | 17.3 | Nitrogen containing hetero ring |
| | 17.5 | Sulfur containing (e.g., methylthiolincosaminide, etc.) |
| | 17.7 | Nitro or nitroso containing |
| | 17.9 | Nitrogen in aglycone moiety |
| | 18.1 | Polycyclo ring system (e.g., hellebrin, etc.) |
| | 18.2 | Containing -C(=X)X- wherein the X's are the same or diverse chalcogens |
| | 18.3 | Plural oxyalkylene groups bonded directly to each other |
| | 18.4 | Halogen containing |
| | 18.5 | Processes |
| | 18.7 | Nitrogen containing |
| | 20 | Chitin or derivative |
| | 21 | Heparin or derivative |
| | 22.1 | N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) |
| | 23.1 | DNA or RNA fragments or modified forms thereof (e.g., genes, etc.) |
| | 23.2 |  Encodes an enzyme |
| | 23.4 | Encodes a fusion protein |
| | 23.5 | Encodes an animal polypeptide |
| | 23.6 | Encodes a plant polypeptide |
| | 23.7 | Encodes a microbial polypeptide |
| | 24.1 | Non-coding sequences which control transcription or translation processes (e.g., promoters, operators, enhancers, ribosome binding sites, etc.) |
| | 24.2 | Non-coding sequences having no known regulatory function which are adaptors or linkers for vector or gene contruction |
| | 24.3 | Probes for detection of specific nucleotide sequences or primers for the synthesis of DNA or RNA |
| | 24.31 |  Probes for detection of animal nucleotide sequences |
| | 24.32 | Probes for detection of microbial nucleotide sequences |
| | 24.33 | Primers |
| | 24.5 | Nucleic acid expression inhibitors |
| | 25.1 | 3-5 linked RNA |
| | 25.2 | 2-5 linked RNA |
| | 25.3 | Synthesis of polynucleotides or oligonucleotides |
| | 25.31 | Deprotection step |
| | 25.32 | Labels or markers utilized (e.g., radiotracer, affinity, fluoroescent, phosphorescent, markers, etc.) |
| | 25.33 | Pentavalent phosphorus compound utilized |
| | 25.34 | Trivalent phosphorus compound utilized |
| | 25.4 | Separation or purification of polynucleotides or oligonucleotides |
| | 25.5 | Homopolymers having repeating sequences of four or more identical nucleotide units |
| | 25.6 | Nucleic acids which include two or three nucleotide units |
| | 26.1 | Phosphorus containing N-glycoside wherein the N is part of an N-hetero ring |
| | 26.11 | The phosphorus is part of a ring |
| | 26.12 | The N-hetero ring is part of a purine ring system |
| | 26.14 | The N-hetero ring is a diazine or a diazole ring, including hydrogenated |
| | 26.2 | Plural phosphorus atoms in N-glycoside |
| | 26.21 | Plural phosphorus atoms bonded directly to the same chalcogen in a chain (e.g., pyrophosphates, polyanhydrides of phosphorus acids, etc.) |
| | 26.22 |  Both terminal phosphorus atoms are esterified by organic groups wherein one of these organic groups is the sugar moiety |
| | 26.26 | Triphosphates (in same chain) |
| | 26.3 | Plural monophosphate groups (e.g., adenosine-3, 5-biscarboxymethyl phosphonate, cytidine nucleoside diphosphate, etc.) |
| | 26.4 | Cobalamin nucleotides (e.g., vitamin B-12, etc.) |
| | 26.41 | Processes of preparing or labelling |
| | 26.42 | Processes of concentraction, separation, recovery, or extraction (e.g., recovery from organ extracts, from fermentation broth, from sewage sludge, etc.) |
| | 26.5 | Plural N-glycosidic moieties bonded to the same phosphorus ester group |
| | 26.6 | Labelled (e.g., tagged with radioactive tracer, fluorescent marker, intercalator, etc.) |
| | 26.7 | The N-hetero ring is part of a bicyclic ring system |
| | 26.71 | Preparing purine nucleotides |
| | 26.73 | Separation or purification of purine nucleotides |
| | 26.74 | Inosine nucleotide |
| | 26.8 | The N-hereto ring is six-membered and monocyclic (e.g., uridine-5-mono- phosphate, etc.) |
| | 26.9 | The N-hereto ring is five-membered (e.g., 1- -D-riboburanosyl-1, 2,3- triazole-4-carboxamide-5-phosphate, etc.) |
| | 27.1 | N-glycosides wherein the N is part of an N-hetero ring which hetero ring is part of a polycyclo ring system containing an N-hetero ring and an additional hetero ring (e.g., rebeccamycin, etc.) |
| | 27.11 | Preparing by cleaving nucleic acids or by attaching an N-heterocyclic base to a sugar ring |
| | 27.12 | Separation or purification (e.g., resolving isomeric mixtures, etc.) |
| | 27.13 | Bicyclic ring system consisting of the N-hetero ring fused to another hetero ring (e.g., 2-azaadenines, 6-azaadenines, etc.) |
| | 27.14 | Multideoxy or didehydro |
| | 27.21 | The five-membered N-hetero ring is 1,3-diazole, which may be hydrogenated (e.g., 6-chloropurine nucleoside, nebularin, etc.) |
| | 27.22 |  Carbonyl, thiocarbonyl, or nitrogen, other than as nitro or nitroso, bonded directly to the sugar ring |
| | 27.23 | Carbonyl, thiocarbonyl, additional hetero ring or nitrogen, other than as nitro or nitroso, attached indirectly to the sugar ring by acyclic nonionic bonding |
| | 27.4 | Arabinose is sugar moiety |
| | 27.5 | Ketose is sugar moiety (e.g., decoyinine, psicofuranosylpurines, etc.) |
| | 27.6 | Nitrogen, other than nitro or nitroso, bonded directly to the 6-position of a purine ring system (e.g., adenosine, etc.) |
| | 27.61 |  Additional nitrogen bonded directly to the 2-position of the purine ring system |
| | 27.62 | Nitrogen, chalcogen, or additional carbon bonded directly to the 6-position nitrogen (e.g., 6-position nitrogen is substituted, etc.) |
| | 27.7 | Chalcogen, halogen, or benzene bonded directly to carbon of the purine ring system (e.g., isoguanosine, 2-fluoroadenosine, etc.) |
| | 27.8 | Chalcogen bonded directly to the 6- or 2-position of a purine ring system (e.g., inosine, etc.) |
| | 28.1 | N-glycosides wherein the N is part of a six-membered hetero ring (e.g., diazines, etc.) |
| | 28.2 | Multideoxy or didehydro |
| | 28.3 | The N-hetero ring is a triazine ring, including hydrogenated (e.g., 6-azauridine, etc.) |
| | 28.4 | The N-hetero ring is a 1,3-diazine ring, including hydrogenated (e.g., pyrimidines, etc.) |
| | 28.5 | Nitrogen, other than nitro or nitroso, bonded directly to the 4-position, and chalcogen bonded directly to the 2-position of the diazine ring (e.g., cytidines, etc.) |
| | 28.51 | Having chalcogen, carbonyl, or thiocarbonyl bonded directly to the 4-position substituent nitrogen |
| | 28.52 | Halogen or alkyl group of 1-5 carbon atoms bonded directly to the 5-position of the diazine ring |
| | 28.53 | Chalcogen bonded directly to the 2- and 4-positions of the diazine ring (e.g., uridine, etc.) |
| | 28.6 | N-glycosides wherein the N is part of a five-membered hetero ring (e.g., selenazole nucleosides, pyrrole nucleosides, etc.) |
| | 29.1 | Nitrogen of N-glycoside is acyclic nitrogen |
| | 29.2 | C-glycosides wherein the sugar ring is bonded directly to carbon of an N-hetero ring (e.g., 9-deazaadenosines, etc.) |
| | 30 | Cellulose derivatives |
| | 31 | Nitrogen containing hetero ring (e.g., morpholine, etc.) |
| | 32 | Esters |
| | 43 | Ethers |
| | 45 | Starch derivatives |
| | 51 | Dextran derivatives |
| | 52 | Gum derivatives |
| | 53 | Oxygen double bonded and nitrogen bonded directly to the same carbon |
| | 54 | Sulfur containing |
| | 55 | Plural nitrogens containing |
| | 55.2 | Glucosamine containing |
| | 55.3 | Processes |
| | 56 | Cellulose or derivative |
| | 57 | Regenerated cellulose |
| | 58 | Esters |
| | 59 | Sulfur containing acid |
| | 62 | Phosphorus containing acid |
| | 63 | Carboxylic acid esters |
| | 64 | Mixed carboxylate esters |
| | 66 | Ether-esters |
| | 67 | Formates |
| | 68 | Propionates, butyrates or isobutyrates |
| | 69 | Acetates |
| | 70 | With pretreatment process |
| | 71 | Acetic acid utilized in pretreatment |
| | 72 | Halogen containing compound utilized in process |
| | 73 | Sulfur containing compound utilized in pretreatment |
| | 74 | Sulfur containing compound utilized in pretreatment |
| | 75 | Halogen containing compound utilized in process |
| | 76 | Subsequent treatment process |
| | 77 | Comminuting or centrifuging |
| | 78 | Recovery from photographic film |
| | 79 | Corrosiveness reduced |
| | 80 | Viscosity or degree of polymerization changed (e.g., degrading, cross linking, etc.) |
| | 81 | Stabilizing |
| | 82 | Halogen containing compound utilized in process |
| | 83 | Halogen containing compound utilized in process |
| | 84 | Ethers |
| | 85 | Subsequent treatment process |
| | 86 | Comminuting |
| | 87 | Liquid interaction properties changed (e.g., solubility, absorbability, etc.) |
| | 88 | Viscosity, degree of polymerization or heat stability changed (e.g., degrading, cross-linking, etc.) |
| | 89 | Acid employed in subsequent treatment |
| | 90 | Mixed ethers |
| | 92 | Sulfur containing |
| | 93 | Unsaturated |
| | 95 | Hydroxyalkyl containing |
| | 97 | Carboxyalkyl or salts thereof |
| | 99 | Alkyl or cycloalkyl |
| | 101 | Metal containing |
| | 102 | Starch or derivative |
| | 103 | Dextrin or derivative |
| | 104 | Aldehyde reaction product |
| | 105 | Oxidized starch or derivative |
| | 106 | Cross-linked |
| | 107 | Esters |
| | 111 | Ethers |
| | 112 | Dextran or derivative |
| | 114 | Gums or derivatives |
| | 115 | Esters |
| | 120 | Ethers |
| | 121 | Metal containing |
| | 122 | Sulfur or halogen containing |
| | 123 | Plural diverse saccharides containing (e.g., hetero polysaccharides, etc.) |
| | 123.1 | Polysaccharides |
| | 123.12 | Glucans (e.g., pullulan, etc.) |
| | 123.13 | Disaccharides (e.g., maltose, sucrose, lactose, formaldehyde lactose, etc.) |
| | 124 | Processes |
| FOREIGN ART COLLECTIONS | ||
| FOR000 | CLASS-RELATED FOREIGN DOCUMENTS |